Effectiveness of different methods for anti-Sm antibody identification. A multicentre study

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 7, 2005, Pages 748-752

  Llorente, María Jesús ^a   Jiménez, Juana ^b   González, Concepción ^c   Alarcón, Inmaculada ^d   Alsina, Monserrat ^e   Casas, Luisa María ^f   Benedito, José Enrique ^g   Araquistain, José Luis ^h   Farre, Victor ⁱ   González Buitrago, José Manuel ^c  

^a HOSPITAL DE MÓSTOLES   (Spain)

^b HOSPITAL SEVERO OCHOA   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^e HOSPITAL MÚTUA DE TERRASSA   (Spain)

^f HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^g HOSPITAL MORALES MESEGUER   (Spain)

^h HOSPITAL MONTECELO   (Spain)

ⁱ HOSPITAL GENERAL DE VIC   (Spain)

Author keywords

Anti Sm antibodies; Autoimmune diseases; Multicentre study

Indexed keywords

SM ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY SCREENING; ARTICLE; AUTOIMMUNE DISEASE; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL LABORATORY; CONTROLLED STUDY; DOT HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNODIFFUSION; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; SPAIN; STANDARDIZATION; STATISTICAL MODEL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; ANTIBODY SPECIFICITY; AUTOANTIGENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNODIFFUSION; LABORATORIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; QUALITY CONTROL; RIBONUCLEOPROTEINS, SMALL NUCLEAR; SPAIN;

EID: 26844452119     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2005.128     Document Type: Article

References (15)

1. Zieve GW, Khusial P. The anti-Sm immune response in autoimmunity and cell biology. Autoimmun Rev 2003; 2:235-40.
2. Habets WJ, Berden JH, Hoch SO, van Venrooij WJ. Further characterization and subcellular localization of Sm and U1 ribonucleoprotein antigens. Eur J Immunol 1985;15:992-7.
3. Hirakata M, Craft J, Hardin JA. Autoantigenic epitopes of the B and D polypeptides of U1 snRNP: analysis of domains recognized by the Y12 monoclonal anti-Sm antibody and by patient sera. J Immunol 1993;150:3592-601.
4. Hoch SO, Eisenberg RA, Sharp GC. Diverse antibody recognition patterns of the multiple Sm-D antigen polypeptides. Clin Immunol 1999;92:204-8.
5. Craft J. Antibodies to snRNPs in systemic lupus erythematosus. Rheum Dis Clin North Am 1992;18:311-35.
6. Gulko PS, Reveille JD, Koopman WJ, Burgard SL, Bartolucci AA, Alarcón GS. Survival impact of autoantibodies in systemic lupus erythematosus. J Rheumatol 1994;21:224-8.
7. Peng SL, Craft JE. Spliceosomal snRNPs autoantibodies. In: Peter JB, Shoenfeld Y, editors. Autoantibodies. Amsterdam: Elsevier Science BV, 1996:774-82.
8. Tan EM, Smolen JS, McDougal JS, Butcher BT, Conn D, Dawkins R, et al. A critical evaluation of enzyme immunoassays for detection of antinuclear antibodies of defined specificities. I. Precision, sensitivity, and specificity. Arthritis Rheum 1999;42:455-64.
9. Tan EM, Smolen JS, McDougal JS, Fritzler MJ, Gordon T, Hardin SA, et al. A critical evaluation of enzyme immunoassays for detection of antinuclear antibodies of defined specificities. II. Potential for quantitation of antibody content. J Rheumatol 2002;29:68-74.
10. Fritzler MJ, Wiik A, Tan EM, Smolen JS, McDougal JS, Chan EK, et al. A critical evaluation of enzyme immunoassays for detection of antinuclear antibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers laboratories. J Rheumatol 2003;30:2374-81.
11. Kavanaugh AF, Solomon DH, Schur P, Reveille JD, Sherrer Y, Lahita R, on behalf of the American College of Rheumatology ad hoc Committee on Immunologic Testing Guidelines. Guidelines for immunologic laboratory testing in the rheumatic diseases: an introduction. Arthritis Rheum 2002;15:429-33.
12. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
13. Alba P, Bento L, Cuadrado MJ, Karim Y, Turgekar MF, Abbs I, et al. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis 2003;62:556-60.
14. Arbuckle M, McClain MT, Rubertone MV, Scofield H, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-33.
15. Arbuckle MR, Reichlin M, Harley JB, James JA. Shared early autoantibody recognition events in the development of anti-Sm B/B′ in human lupus. Scand J Immunol 1999;50:447-55.